nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Patient-Centric, Open-Label, Multicenter, Phase II Study of Lorlatinib Monotherapy in the First-Line Treatment of Patients With locally Advanced or Metastatic ALK-Positive Non-Small Cell Lung Cancer (CTONG2203)
|
Lin, Jia-Xin |
|
|
26 |
6 |
p. 515-519 |
artikel |
2 |
A Propensity-Matched Comparison Between Minimally Invasive Surgery and Stereotactic Radiotherapy in the Treatment of Clinical Stage IA Non–Small-Cell Lung Cancer (NSCLC)
|
Josephides, Eleni |
|
|
26 |
6 |
p. e399-e408.e2 |
artikel |
3 |
A Review of Focal Therapies for Small Cell Lung Cancer Brain Metastases
|
Robinson, Stephen David |
|
|
26 |
6 |
p. 441-457 |
artikel |
4 |
Baseline Characteristics of Participants and Pulmonary Nodules in the Watch the Spot Trial: A Pragmatic Trial of Less versus More Intensive Strategies for Active Surveillance of Patients With Small Pulmonary Nodules
|
Gould, Michael K. |
|
|
26 |
6 |
p. e472-e482.e1 |
artikel |
5 |
Breaking Through: Immunotherapy Innovations in Pleural Mesothelioma
|
Sofianidi, Amalia A. |
|
|
26 |
6 |
p. 458-469 |
artikel |
6 |
Chemotherapy Plus Anti-PD-1 or Anti-PD-L1 in Advanced PD-L1–Negative Squamous Cell Lung Carcinoma: A Systematic Review and Meta-Analysis
|
Peruzzo, Nicolas |
|
|
26 |
6 |
p. e361-e373 |
artikel |
7 |
Combined Impact of Coronary Artery Calcification and Heart Radiation Dose on Overall Survival in Locally Advanced Non-Small Cell Lung Cancer: Who Benefits Most from Reducing Heart Radiation Dose?
|
Watanabe, Yui |
|
|
26 |
6 |
p. e420-e431.e4 |
artikel |
8 |
Common Medical Comorbidities Influence Pneumonitis Risk After Chemoradiotherapy and Durvalumab Maintenance in Stage III Non–small Cell Lung Cancer
|
Ohaegbulam, Kim |
|
|
26 |
6 |
p. e382-e390.e2 |
artikel |
9 |
Correlation of PET-CT, Endobronchial Ultrasound Cytology and Surgical Biopsy in Patients with Non-Small Cell Lung Cancer Undergoing Curative Surgery
|
Rakedzon, Stav |
|
|
26 |
6 |
p. e465-e471 |
artikel |
10 |
Distinct Role of TP53 Co-mutations in Different EGFR Subtypes Mediating the Response to EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
|
Wei, Lihong |
|
|
26 |
6 |
p. 478-491.e7 |
artikel |
11 |
Editorial Board
|
|
|
|
26 |
6 |
p. A1 |
artikel |
12 |
Efficacy and Safety of EGFR-TKI Combined With Early Brain Radiotherapy Versus TKI Alone in Patients With EGFR-Mutated NSCLC With Brain Metastases: A Systematic Review and Meta-Analysis
|
Zeng, Zihan |
|
|
26 |
6 |
p. e391-e398 |
artikel |
13 |
Evaluating Diagnostic and Treatment Timelines for ALK-Positive NSCLC Patients: Results From a Global Registry
|
Bazzi, Hayat |
|
|
26 |
6 |
p. 470-477 |
artikel |
14 |
Impact of TP53 Co-Mutation on Clinicopathological Features, Prognosis, Recurrence Patterns, and the Efficacy of EGFR-TKI Treatment After Recurrence in Resected Early-Stage EGFR-Mutated Lung Adenocarcinoma
|
Masuda, Tatsuya |
|
|
26 |
6 |
p. e374-e381 |
artikel |
15 |
KRAS ctDNA Detection in Patients With Resectable Lung Adenocarcinoma
|
De Meo, Meghan L. |
|
|
26 |
6 |
p. e447-e455.e6 |
artikel |
16 |
Maximizing Lung Cancer Screening in High-Risk Population Leveraging ML-Developed Risk-Prediction Algorithms: Danish Retrospective Validation of LungFlag
|
Henriksen, Margrethe Bang |
|
|
26 |
6 |
p. 520-525 |
artikel |
17 |
Mortality in a Diverse, Real-World Lung Cancer Screening Cohort
|
Gwin, Mary E. |
|
|
26 |
6 |
p. e441-e446 |
artikel |
18 |
Multiple Sclerosis and Lung Cancer: A Single Cancer Center Experience in Philadelphia
|
Palecki, Julia |
|
|
26 |
6 |
p. e409-e412 |
artikel |
19 |
Outcomes Following First-Line Immune Checkpoint Inhibitors With or Without Chemotherapy Stratified by KRAS Mutational Status—A Real-World Analysis in Patients With Advanced NSCLC
|
Cantor, David J. |
|
|
26 |
6 |
p. 503-510.e4 |
artikel |
20 |
Phase II Trial of LP-300 in Combination With Carboplatin and Pemetrexed in Never Smoker Patients With Relapsed Advanced Primary Adenocarcinoma of the Lung After Treatment With Tyrosine Kinase Inhibitors
|
Bodor, J. Nicholas |
|
|
26 |
6 |
p. 511-514 |
artikel |
21 |
Postoperative Pain Reduction and Clinical Value of Uniportal Video-Assisted Thoracic Surgery: A Secondary Analysis of the J-RATSIG 01 Study
|
Watanabe, Takuya |
|
|
26 |
6 |
p. e413-e419.e2 |
artikel |
22 |
Real-life Experience of Rare Hepatoid Adenocarcinomas of the Lung: A Large Retrospective French Cohort
|
Fave, Thomas |
|
|
26 |
6 |
p. e432-e440 |
artikel |
23 |
Real-World Creatinine-Based Estimates of Acute and Chronic Kidney Dysfunction in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung Cancer Receiving Tyrosine Kinase Inhibitors
|
Pinard, Louis |
|
|
26 |
6 |
p. 492-502 |
artikel |
24 |
Table of Contents
|
|
|
|
26 |
6 |
p. A3-A6 |
artikel |